Elliott Joseph Brea, M.D., Ph.D.
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
Chemoprevention | 1 | 2021 | 319 | 0.670 |
Why?
|
Risk Adjustment | 1 | 2021 | 594 | 0.600 |
Why?
|
Phosphotransferases | 1 | 2016 | 308 | 0.520 |
Why?
|
Histocompatibility Antigens Class I | 2 | 2019 | 1366 | 0.470 |
Why?
|
Venous Thromboembolism | 1 | 2021 | 1671 | 0.330 |
Why?
|
Carcinoma, Non-Small-Cell Lung | 2 | 2023 | 5221 | 0.290 |
Why?
|
Anticoagulants | 1 | 2021 | 4599 | 0.270 |
Why?
|
WT1 Proteins | 2 | 2015 | 178 | 0.240 |
Why?
|
Neoplasms | 4 | 2021 | 21683 | 0.200 |
Why?
|
Pyrimidines | 4 | 2019 | 2942 | 0.190 |
Why?
|
Lung Neoplasms | 2 | 2023 | 13102 | 0.190 |
Why?
|
Gene Expression Regulation, Neoplastic | 1 | 2016 | 8428 | 0.180 |
Why?
|
Risk Assessment | 1 | 2021 | 23338 | 0.180 |
Why?
|
Pneumonia, Pneumocystis | 1 | 2020 | 249 | 0.160 |
Why?
|
HLA-A2 Antigen | 2 | 2015 | 213 | 0.160 |
Why?
|
Proto-Oncogene Proteins c-ret | 1 | 2019 | 220 | 0.150 |
Why?
|
Pharmacokinetics | 1 | 2016 | 88 | 0.140 |
Why?
|
HLA-A Antigens | 1 | 2016 | 231 | 0.140 |
Why?
|
Nanotubes, Carbon | 1 | 2016 | 73 | 0.130 |
Why?
|
Histone Deacetylase Inhibitors | 2 | 2017 | 789 | 0.130 |
Why?
|
Lymphoma, Non-Hodgkin | 1 | 2021 | 1381 | 0.120 |
Why?
|
Morpholines | 1 | 2017 | 571 | 0.120 |
Why?
|
Protein-Tyrosine Kinases | 1 | 2023 | 2455 | 0.120 |
Why?
|
Melanoma, Experimental | 1 | 2016 | 561 | 0.110 |
Why?
|
Myeloid Differentiation Factor 88 | 1 | 2017 | 571 | 0.110 |
Why?
|
Protein Kinase Inhibitors | 3 | 2019 | 5535 | 0.110 |
Why?
|
Histone Deacetylases | 1 | 2017 | 728 | 0.100 |
Why?
|
Proto-Oncogene Proteins p21(ras) | 1 | 2019 | 1692 | 0.100 |
Why?
|
Antigens, Neoplasm | 1 | 2019 | 1988 | 0.100 |
Why?
|
Mice, Transgenic | 3 | 2019 | 9734 | 0.090 |
Why?
|
Proto-Oncogene Proteins | 1 | 2023 | 4554 | 0.090 |
Why?
|
Lymphoma, B-Cell | 1 | 2017 | 931 | 0.090 |
Why?
|
Cell Line, Tumor | 5 | 2019 | 16689 | 0.090 |
Why?
|
Nuclear Magnetic Resonance, Biomolecular | 1 | 2012 | 507 | 0.090 |
Why?
|
MAP Kinase Signaling System | 1 | 2016 | 1526 | 0.080 |
Why?
|
Patient Selection | 1 | 2021 | 4215 | 0.080 |
Why?
|
Leukemia, Myelogenous, Chronic, BCR-ABL Positive | 1 | 2014 | 689 | 0.080 |
Why?
|
Antibodies, Monoclonal | 2 | 2016 | 9274 | 0.080 |
Why?
|
RNA Interference | 1 | 2016 | 2889 | 0.080 |
Why?
|
Antibodies | 1 | 2015 | 2460 | 0.070 |
Why?
|
RNA, Small Interfering | 1 | 2016 | 3505 | 0.070 |
Why?
|
Lymphoma, Large B-Cell, Diffuse | 1 | 2017 | 1378 | 0.070 |
Why?
|
Receptors, Antigen, T-Cell | 1 | 2016 | 2540 | 0.070 |
Why?
|
Thiazoles | 1 | 2014 | 1483 | 0.070 |
Why?
|
CD8-Positive T-Lymphocytes | 2 | 2019 | 4479 | 0.070 |
Why?
|
Pyrazoles | 1 | 2017 | 1972 | 0.070 |
Why?
|
Mutation | 2 | 2023 | 29786 | 0.070 |
Why?
|
Antineoplastic Agents | 2 | 2017 | 13695 | 0.060 |
Why?
|
Mice | 7 | 2019 | 81183 | 0.050 |
Why?
|
Coronavirus Infections | 1 | 2020 | 3133 | 0.050 |
Why?
|
Pneumonia, Viral | 1 | 2020 | 3240 | 0.050 |
Why?
|
T-Lymphocytes | 1 | 2019 | 10180 | 0.050 |
Why?
|
Disease Models, Animal | 2 | 2019 | 18029 | 0.050 |
Why?
|
Immunotherapy | 1 | 2016 | 4445 | 0.050 |
Why?
|
Liver | 1 | 2016 | 7474 | 0.050 |
Why?
|
Animals | 9 | 2019 | 168757 | 0.050 |
Why?
|
Pneumocystis carinii | 1 | 2020 | 74 | 0.040 |
Why?
|
Humans | 12 | 2023 | 744343 | 0.040 |
Why?
|
Xenograft Model Antitumor Assays | 2 | 2017 | 3557 | 0.040 |
Why?
|
Lymphopenia | 1 | 2020 | 285 | 0.040 |
Why?
|
Sulfones | 1 | 2019 | 437 | 0.040 |
Why?
|
Pyrimidinones | 1 | 2019 | 371 | 0.040 |
Why?
|
Antineoplastic Combined Chemotherapy Protocols | 1 | 2017 | 11524 | 0.030 |
Why?
|
Membrane Proteins | 1 | 2012 | 7880 | 0.030 |
Why?
|
Molecular Mimicry | 1 | 2016 | 201 | 0.030 |
Why?
|
Treatment Outcome | 1 | 2021 | 63114 | 0.030 |
Why?
|
Antibodies, Neoplasm | 1 | 2016 | 286 | 0.030 |
Why?
|
Pyridones | 1 | 2019 | 712 | 0.030 |
Why?
|
Macaca fascicularis | 1 | 2016 | 915 | 0.030 |
Why?
|
CD4 Lymphocyte Count | 1 | 2020 | 2559 | 0.030 |
Why?
|
Benzimidazoles | 1 | 2019 | 850 | 0.030 |
Why?
|
Antigen Presentation | 1 | 2019 | 1284 | 0.030 |
Why?
|
Deuterium | 1 | 2012 | 101 | 0.030 |
Why?
|
STAT3 Transcription Factor | 1 | 2017 | 873 | 0.030 |
Why?
|
Drug Synergism | 1 | 2017 | 1792 | 0.030 |
Why?
|
Materials Testing | 1 | 2016 | 867 | 0.030 |
Why?
|
Immunotherapy, Adoptive | 1 | 2021 | 1270 | 0.030 |
Why?
|
Endocytosis | 1 | 2016 | 985 | 0.030 |
Why?
|
Adenine | 1 | 2017 | 936 | 0.030 |
Why?
|
Pharmacogenetics | 1 | 2015 | 675 | 0.020 |
Why?
|
Crystallography, X-Ray | 1 | 2015 | 2011 | 0.020 |
Why?
|
Protein Disulfide-Isomerases | 1 | 2012 | 198 | 0.020 |
Why?
|
Enzyme-Linked Immunosorbent Assay | 1 | 2017 | 3870 | 0.020 |
Why?
|
Mass Spectrometry | 1 | 2017 | 2203 | 0.020 |
Why?
|
Epitopes | 1 | 2016 | 2571 | 0.020 |
Why?
|
Blotting, Western | 1 | 2017 | 5179 | 0.020 |
Why?
|
Piperidines | 1 | 2017 | 1602 | 0.020 |
Why?
|
Mice, SCID | 1 | 2014 | 2716 | 0.020 |
Why?
|
Protein Conformation | 1 | 2015 | 4011 | 0.020 |
Why?
|
Polymerase Chain Reaction | 1 | 2017 | 6171 | 0.020 |
Why?
|
Mice, Inbred BALB C | 1 | 2016 | 6386 | 0.020 |
Why?
|
Peptides | 1 | 2019 | 4409 | 0.020 |
Why?
|
Protons | 1 | 2012 | 1127 | 0.020 |
Why?
|
alpha-Synuclein | 1 | 2012 | 723 | 0.020 |
Why?
|
CD4-Positive T-Lymphocytes | 1 | 2019 | 4386 | 0.020 |
Why?
|
Flow Cytometry | 1 | 2017 | 5974 | 0.020 |
Why?
|
Enzyme Inhibitors | 1 | 2017 | 3798 | 0.020 |
Why?
|
Escherichia coli Proteins | 1 | 2012 | 1050 | 0.020 |
Why?
|
Models, Molecular | 1 | 2015 | 5456 | 0.020 |
Why?
|
Promoter Regions, Genetic | 1 | 2017 | 5867 | 0.020 |
Why?
|
Survival Rate | 1 | 2019 | 12788 | 0.020 |
Why?
|
Protein Binding | 1 | 2015 | 9386 | 0.010 |
Why?
|
Transcription, Genetic | 1 | 2017 | 7722 | 0.010 |
Why?
|
Cell Proliferation | 1 | 2017 | 10481 | 0.010 |
Why?
|
Mice, Inbred C57BL | 1 | 2019 | 21827 | 0.010 |
Why?
|
Apoptosis | 1 | 2017 | 9727 | 0.010 |
Why?
|
Female | 4 | 2020 | 380194 | 0.010 |
Why?
|
Pandemics | 1 | 2020 | 8388 | 0.010 |
Why?
|
Cell Line | 1 | 2014 | 15997 | 0.010 |
Why?
|
Drug Resistance, Neoplasm | 1 | 2014 | 5172 | 0.010 |
Why?
|
Bacterial Proteins | 1 | 2012 | 3848 | 0.010 |
Why?
|
Male | 3 | 2019 | 350118 | 0.010 |
Why?
|
Aged | 1 | 2020 | 163280 | 0.000 |
Why?
|
Middle Aged | 1 | 2021 | 213383 | 0.000 |
Why?
|